Skip to content

Video Forum: Joe DePinto, McKesson

New division takes aim at cell and gene therapies.

Joe DePinto, head of cell, gene and advanced therapies at McKesson.

Table of Contents

In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed. 

Comments

Latest